Cumulative annual coverage of meningococcal B vaccination in Australian general practice for three at-risk groups, 2014 to 2019

References

• Stephens DS, Greenwood B, Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet. 2007;369:2196–210. doi:10.1016/S0140-6736(07)61016-2.
   PubMed Web of Science ®Google Scholar
• Rouphael NG, Stephens DS. Neisseria meningitidis: biology, microbiology, and epidemiology. Methods Mol Biol. 2012;799:1–20.
   PubMedGoogle Scholar
• Burman C, Serra L, Nuttens C, Presa J, Balmer P, York L. Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination. Hum Vaccin Immunother. 2019;15:459–69. doi:10.1080/21645515.2018.1528831.
   PubMed Web of Science ®Google Scholar
• Australian Government Department of Health. Invasive meningococcal disease National Surveillance Report. Semester 1: 1 January to 30 June 2019. Canberra (ACT). 2019 [accessed 2021 Feb 05]. https://www1.health.gov.au/internet/main/publishing.nsf/Content/5FEABC4B495BDEC1CA25807D001327FA/$File/IMD-surveil-report-Jan-June-2019.pdf .
   Google Scholar
• Vuocolo S, Balmer P, Gruber WC, Jansen KU, Anderson AS, Perez JL, York LJ. Vaccination strategies for the prevention of meningococcal disease. Hum Vaccin Immunother. 2018;14:1203–15. doi:10.1080/21645515.2018.1451287.
   PubMed Web of Science ®Google Scholar
• Leca M, Bornet C, Montana M, Curti C, Vanelle P. Meningococcal vaccines: current state and future outlook. Pathologie-biologie. 2015;63:144–51. doi:10.1016/j.patbio.2015.04.003.
   PubMed Web of Science ®Google Scholar
• Archer BN, Chiu CK, Jayasinghe SH, Richmond PC, McVernon J, Lahra MM, Andrews RM, McIntyre PB. Epidemiology of invasive meningococcal B disease in Australia, 1999-2015: priority populations for vaccination. Med J Aust. 2017;207:382–87. doi:10.5694/mja16.01340.
   PubMed Web of Science ®Google Scholar
• Marshall HS, McMillan M, Koehler AP, Lawrence A, Sullivan TR, MacLennan JM, Maiden MCJ, Ladhani SN, Ramsay ME, Trotter C, et al. Meningococcal B vaccine and meningococcal carriage in adolescents in Australia. N Engl J Med. 2020;382(4):318–27. doi:10.1056/NEJMoa1900236.
   PubMed Web of Science ®Google Scholar
• National Centre for Immunisation Research and Surveillance. Significant events in meningococcal vaccination practice in Australia; Sydney (NSW): National Centre for Immunisation Research and Surveillance; 2020 [accessed 2020 Aug 10]. https://www.ncirs.org.au/sites/default/files/2020-07/Meningococcal-history-July%202020.pdf .
   Google Scholar
• Australian Technical Advisory Group on Immunisation (ATAGI). Australian immunisation handbook. Canberra (ACT): Australian Government Department of Health; 2020 [accessed 2021 Mar 15]. https://immunisationhandbook.health.gov.au .
   Google Scholar
• Pharmaceutical Benefits Advisory Committee. Public Summary Document - November 2019 PBAC Meeting: Multicomponent Meningococcal group B vaccine: Injection 0.5 mL; Bexsero®. Canberra (ACT): PharmaceuticalBenefits Scheme; 2019 [accessed 2020 Dec 11]. https://www.pbs.gov.au/pbs/industry/listing/elements/pbac-meetings/psd/2019-11/multicomponent-meningococcal-group-b-vaccine-injection-0-5-bexsero .
   Google Scholar
• Snape MD, Medini D, Halperin SA, DeTora L, Drori J, Moxon ER. The challenge of post-implementation surveillance for novel meningococcal vaccines. Vaccine. 2012;30(Suppl 2):B67–72. doi:10.1016/j.vaccine.2011.12.126.
   PubMed Web of Science ®Google Scholar
• Brynley Hull A, Dey A, Macartney K, McIntyre P, Beard F. Exploratory analysis of the first 2 years of adult vaccination data recorded on AIR. Sydney (NSW): National Centre for Immunisation Research and Surveillance; 2019.
   Google Scholar
• Tuckerman J, Blyth CC, Beard FH, Danchin MH. COVID-19 and changes in the National Immunisation Program: a unique opportunity to optimise the Australian Immunisation Register (AIR). Med J Aust. 2021;214(247–9.e1):247. doi:10.5694/mja2.50971.
   PubMed Web of Science ®Google Scholar
• Lin J, Wood JG, Bernardo C, Stocks NP, Liu B. Herpes zoster vaccine coverage in Australia before and after introduction of a national vaccination program. Vaccine. 2020;38:3646–52. doi:10.1016/j.vaccine.2020.03.036.
   PubMed Web of Science ®Google Scholar
• Frank O, De Oliveira Bernardo C, Gonzalez-Chica DA, Macartney K, Menzies R, Stocks N. Pneumococcal vaccination uptake among patients aged 65 years or over in Australian general practice. Hum Vaccin Immunother. 2020;16:965–71. doi:10.1080/21645515.2019.1682844.
   PubMed Web of Science ®Google Scholar
• De Oliveira Bernardo C, Gonzalez-Chica DA, Stocks N. Impact of funding influenza vaccination on coverage among Australian children: a national study using MedicineInsight, a large general practice database. Hum Vaccin Immunother. 2020;16:630–35. doi:10.1080/21645515.2019.1664866.
   PubMed Web of Science ®Google Scholar
• De Oliveira Bernardo C, Gonzalez-Chica DA, Chilver M, Stocks N. Influenza immunisation coverage from 2015 to 2017: a national study of adult patients from Australian general practice. Vaccine. 2019;37:4268–74. doi:10.1016/j.vaccine.2019.06.057.
   PubMed Web of Science ®Google Scholar
• Busingye D, Gianacas C, Pollack A, Chidwick K, Merrifield A, Norman S, Mullin B, Hayhurst R, Blogg S, Havard A, et al. Data resource profile: medicineInsight, an Australian national primary health care database. Int J Epidemiol. 2019;48:1741–h.
   PubMed Web of Science ®Google Scholar
• NPS MedicineWise. MedicineInsight general practice insights report: July 2018 – June 2019. NPS MedicineWise: Sydney (NSW); 2020 [accessed 2020 Nov 15]. https://www.nps.org.au/assets/Report-2018-19-GPIR.pdf
   Google Scholar
• The Royal Australian College of General Practitioners (RACGP). Standards for general practices. East Melbourne (Victoria): RACGP; 2017.
   Google Scholar
• Rodríguez-Rieiro C, Domínguez-Berjón MF, Esteban-vasallodomínguez-berjón MD, Cuadrado AR, Carrasco-Garrido P, Jiménez-García R. Coverage and predictors of influenza vaccine uptake among adults aged 16 to 59 years suffering from a chronic condition in Madrid, Spain. Hum Vaccin. 2011;7:557–62. doi:10.4161/hv.7.5.14984.
   PubMed Web of Science ®Google Scholar
• Chen CH, Wu MS, Wu IC. Vaccination coverage and associated factors for receipt of the 23-valent pneumococcal polysaccharide vaccine in Taiwan: a nation-wide community-based study. Medicine. 2018;97:e9773. doi:10.1097/MD.0000000000009773.
   PubMed Web of Science ®Google Scholar
• Looijmans-van den Akker I, van den Heuvel Pm Fau - Verheij TJM, Verheij Tj Fau - van Delden JJM, van Delden Jj Fau - van Essen GA, van Essen Ga Fau - Hak E, Hak E. No intention to comply with influenza and pneumococcal vaccination: behavioural determinants among smokers and non-smokers. Prev Med. 2007;45:380–85. doi:10.1016/j.ypmed.2007.07.009.
   PubMed Web of Science ®Google Scholar
• Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med. 2004;164:2206–16. doi:10.1001/archinte.164.20.2206.
   PubMed Web of Science ®Google Scholar
• Stuart J, Robinson P, Cartwright KV, Noah N. Effect of smoking on meningococcal carriage. Lancet. 1989;334:723–25. doi:10.1016/S0140-6736(89)90781-2.
   Web of Science ®Google Scholar
• Bianchi FP, Stefanizzi P, Spinelli G, Mascipinto S, Tafuri S. Immunization coverage among asplenic patients and strategies to increase vaccination compliance: a systematic review and meta-analysis. Expert Rev Vaccines. 2021;20:1–12. doi:10.1080/14760584.2021.1886085.
   PubMed Web of Science ®Google Scholar
• Holloway IW, Bednarczyk R, Fenimore VL, Goldbeck C, Wu E, Himmelstein R, Tan D, Randall L, Lutz CS, Frew PM. Factors Associated with Immunization Opinion Leadership among Men Who Have Sex with Men in Los Angeles, California. Int J Environ Res Public Health. 2018;15(5):939. doi:10.3390/ijerph15050939.
   Google Scholar
• Frew PM, Holloway IW, Goldbeck C, Tan D, Wu E, Jauregui J, Fenimore VL, Randall LA, Lutz CS, Mendel J, et al. Development of a measure to assess vaccine confidence among men who have sex with men. Expert Rev Vaccines. 2018;17:1053–61. doi:10.1080/14760584.2018.1541405.
   PubMed Web of Science ®Google Scholar
• Martin-Sanchez M, Fairley CK, Bradshaw CS, Chen MY, Chow EPF. Meningococcal vaccine uptake among men who have sex with men in response to an invasive meningococcal C disease outbreak in Melbourne, Australia. Sex Transm Infect. 2020;96(4):246–50. doi:10.1136/sextrans-2019-054318.
   PubMed Web of Science ®Google Scholar
• Hendry A, Hull B, Dey A, Reid S, Ennis S, Macartney K, Beard F. NSW annual immunisation coverage report 2018; Sydney (NSW): NSW Health; 2019. [accessed 2020 Nov 11]. https://www.health.nsw.gov.au/immunisation/Documents/2018-annual-coverage-report.pdf .
   Google Scholar
• Queesland Government. Queensland school immunisation program: 2019 annual report. 2020.
   Google Scholar
• Dyda A, McIntyre P, Karki S, MacIntyre CR, Newall AT, Banks E, Kaldor J, Liu B. Pertussis vaccination in a cohort of older Australian adults following a cocooning vaccination program. Vaccine. 2018;36:4157–60. doi:10.1016/j.vaccine.2018.05.109.
   PubMed Web of Science ®Google Scholar
• Ward K, Quinn H, Menzies R, McIntyre P. A history of adolescent school based vaccination in Australia. Commun Dis Intell Q Rep. 2013;37:E168–74.
   PubMedGoogle Scholar
• Kassianos G, MacDonald P, Aloysius I, Reynolds A. Implementation of the United Kingdom’s childhood influenza national vaccination programme: a review of clinical impact and lessons learned over six influenza seasons. Vaccine. 2020;38:5747–58. doi:10.1016/j.vaccine.2020.06.065.
   PubMed Web of Science ®Google Scholar
• OECD. Purchasing power parities (PPP) (indicator). 2021. [accessed 2021 Mar 02]. doi: 10.1787/1290ee5a-en.
   Google Scholar
• Chemist Warehouse. Price of meningococcal B vaccines Trumenba and Bexsero for private prescription. 2021 [accessed 2021 Mar 02]. https://www.chemistwarehouse.com.au
   Google Scholar
• Taylor KA, Stocks N, Marshall HS. The missing link: family physician perspectives on barriers and enablers to prescribing a new Meningococcal B vaccine and other recommended, non-government funded vaccines. Vaccine. 2014;32:4214–19. doi:10.1016/j.vaccine.2014.04.046.
   PubMed Web of Science ®Google Scholar
• Hull B, Hendry A, Dey A, Brotherton J, Macartney K, Beard F. Annual immunisation coverage report 2017. Commun Dis Intell. 2018;2019:43. doi: 10.33321/cdi.2019.43.47.
   Google Scholar
• Marshall H, Clarke M, Sullivan T. Parental and community acceptance of the benefits and risks associated with meningococcal B vaccines. Vaccine. 2014;32:338–44. doi:10.1016/j.vaccine.2013.11.042.
   PubMed Web of Science ®Google Scholar
• Azzari C, Diez-Domingo J, Eisenstein E, Faust SN, Konstantopoulos A, Marshall GS, Rodrigues F, Schwarz TF, Weil-Olivier C. Experts’ opinion for improving global adolescent vaccination rates: a call to action. Eur J Pediatr. 2020;179:547–53. doi:10.1007/s00431-019-03511-8.
   PubMed Web of Science ®Google Scholar
• Hunter PMD, Fryhofer SAMD, Szilagyi PGMDMPH. Vaccination of adults in general medical practice. Mayo Clin Proc. 2020;95:169–83. doi:10.1016/j.mayocp.2019.02.024.
   PubMed Web of Science ®Google Scholar